Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nine Oxford academics have received European Research Council (ERC) Advanced Grants to fund cutting-edge research projects that address some of today’s most pressing challenges.

 

The awards, funded through the EU and worth up to €2.5 million each, allow established top researchers from across disciplines to explore their most creative ideas. The grants will also lead to the creation of jobs including postdoctoral and doctoral research positions.

Projects led by Oxford include one that will make synthetic tissues for applications in medicine, and another probing the information flows between companies and consumers, filling a gap in economic understanding and policy.

The Oxford researchers receiving awards in the latest round of funding are:

  • Professor Mark Armstrong, Department of Economics          
  • Professor Hagan Bayley, Department of Chemistry
  • Professor Benjamin Berks, Department of Biochemistry
  • Professor Veronique Gouverneur, Department of Chemistry        
  • Professor Marta Kwiatkowska, Department of Computer Science
  • Professor Gero Miesenboeck, Department of Physiology, Anatomy and Genetics
  • Professor Melinda Mills, Department of Sociology
  • Professor Judith Rousseau, Department of Statistics
  • Professor Stuart West, Department of Zoology

Read more (University of Oxford website)

Similar stories

Forecasting how best to control and eliminate Neglected Tropical Diseases

Neglected tropical diseases (NTDs) are a major cause of death, disability, and economic hardship worldwide, particularly in low- and middle-income countries. While many of these diseases are targeted for control, elimination, or eradication by 2030, achieving those targets will be challenging due to disruptions to programmes related to the COVID-19 pandemic and differences in disease transmission across regions, which requires tailoring interventions to local settings.